Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study
- C. R. Rowan
- , D. Keegan
- , K. Byrne
- , G. Cullen
- , H. E. Mulcahy
- , J. Sheridan
- , E. J. Ryan
- , A. de Vries
- , G. D'Haens
- , G. A. Doherty
- University College Dublin
- Sanquin Blood Supply Foundation
- Amsterdam UMC - University of Amsterdam
Research output: Contribution to journal › Article › peer-review